Acetergamine
This article relies largely or entirely on a single source. (March 2024) |
![]() | |
Names | |
---|---|
Systematic IUPAC name N-{[(8β)-6-Methylergolin-8-yl]methyl}acetamide | |
Other names 8β-acetylaminomethyl-6-methylergoline (+)-N-Acetyl-9,10-dihydrolysergamine | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
ECHA InfoCard | 100.019.281 |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C18H23N3O | |
Molar mass | 297.402 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Acetergamine is an organic chemical compound; specifically it is a derivative of ergoline, making it a member of the ergotamine family of compounds. Acetergamine currently has no mainstream uses, however its potential as an alpha-1 blocker and vasodilator has led to it being covered in several patents concerning therapies for erectile dysfunction. It has also been investigated as a treatment for cerebellar ataxia.[1]
References
[edit]